DAR AL-SHIFA PHARMACEUTICALS | ALWatanieh Securities Co
User Name       اسم المستخدم
Password       كلمة المرور
Language   English             عربي  اللغة
     
%0.32 | 1.68
Opened

DAR AL-SHIFA PHARMACEUTICALS (PHARMACARE.D)
YearTotal revenuesTotal expensesNet income - LossEPSDividendsCapitalSubscribed CapitalMarket Cap($)
20180000.3168,462,6238,462,62330,888,574
201600456,7040.1810,000,0008,462,6230
2015001,643,3040.228% Cash10,000,0008,462,6230
201415,634,1143,337,508945,3630.178% Cash10,000,0008,462,62331,650,210
201315,906,2323,442,5802,117,6850.28% Cash8,462,6238,462,62333,427,361
201215,364,2264,102,7622,027,9720-8,462,6238,462,6230
201119,464,1543,626,4562,028,8900-8,462,6238,462,6230
Cor Act Type DescAnnouncement DateExDividend dateRecord DateOutstanding Shares BeforeNo New SharesOutstanding Shares AfterPayment DateTo Payment Date
Change the par value from JD to USD5/9/20135/12/20136/12/20136,000,0002,462,6238,462,6236/12/20136/12/2013
General-Assembly-Decisions-PHARMACARE-20190808
General-Assembly-Decisions-PHARMACARE-20190808
Board-Meeting-Decisions-PHARMACARE-20190808
FS-Audited-2018-PHARMACARE-31072019.pdf
Board-Meeting-Date-PHARMACARE-20190808
General-Assembly-Date-PHARMACARE-20190808
Adding-NewShares-PHARMACARE--20062019.pdf
Adding-NewShares--PHARMACARE--20062019.pdf
FS-Quarter1-2019-PHARMACARE-02052019.pdf
Board-Meeting-Decisions-PHARMACARE-20190317
Board-Meeting-Date-PHARMACARE-20190314
FS-Annual-Preliminary-2018-PHARMACARE-18022019.pdf
Board-Meeting-Decisions-PHARMACARE-20181205
Board-Meeting-Date-PHARMACARE-20181205
FS-Quarter3-2018-PHARMACARE-31102018.pdf
FS-Semi-Annual-2018-PHARMACARE-03092018.pdf
Board-Meeting-Decisions-PHARMACARE-20180809
General-Assembly-Decisions-PHARMACARE-20180809
General-Assembly-Decisions-PHARMACARE-20180809
Annual-Report-2017-PHARMACARE-12082018.pdf
Board-Meeting-Date-PHARMACARE-20180731
General-Assembly-Date-PHARMACARE-20180725
General-Assembly-Date-PHARMACARE-20180725
FS-Quarter1-2018-PHARMACARE--30042018.pdf
Board-Meeting-Decisions-PHARMACARE-20180425
Board-Meeting-Date-PHARMACARE-20180424
Board-Meeting-Date-PSE-20180305
Insiders Trading Activities-PHARMACARE-20171011
Insiders Trading Activities-PHARMACARE-20171011
Insiders Trading Activities-PHARMACARE-20171025
Insiders Trading Activities-PHARMACARE-20171102
Owner Percantage Change-PHARMACARE-20171120
Board-Meeting-Date-JCC-20171220
Board-Meeting-Date-PIIC-20180214
Board-Meeting-Date-PSE-20180305
Annual-Report-2013-PHARMACARE-09062014
Annual-Report-2014-PHARMACARE-15062015
Board-Meeting-Decisions-PHARMACARE-20180215
Insiders Trading Activities-PHARMACARE-20171011
Insiders Trading Activities-PHARMACARE-20171011
Insiders Trading Activities-PHARMACARE-20171025
Insiders Trading Activities-PHARMACARE-20171102
Owner Percantage Change-PHARMACARE-20171120
Board-Meeting-Decisions-JPH-20171114
Board-Meeting-Date-PALAQAR-20171212
Board-Meeting-Date-PHARMACARE-20180215
FS-Annual-Preliminary-2017-PHARMACARE-15022018.pdf
Board-Meeting-Date-PHARMACARE-20180215
Board-Meeting-Decisions-PHARMACARE-20171121
Board-Meeting-Date-PHARMACARE-20171121
Owner Percantage Change-PHARMACARE-20171120
Insiders Trading Activities-PHARMACARE-20171102
FS-Quarter3-2017-PHARMACARE-31102017.pdf
Insiders Trading Activities-PHARMACARE-20171025
Insiders Trading Activities-PHARMACARE-20171011
Insiders Trading Activities-PHARMACARE-20171011
Annual-Report-2013-PHARMACARE-09062014
Annual-Report-2014-PHARMACARE-15062015
Discl_Related Parties_PHARMACARE_07092017.pdf
Discl_Related Parties_PHARMACARE_06092017.pdf
Discl_Related Parties1_PHARMACARE_06092017.pdf
Annual-Report-2016-PHARMACARE-23082017.pdf
General-Assembly-Decisions-PHARMACARE-23082017.pdf
Board-Meeting-Decisions-PHARMACARE-23082017.pdf
FS-Semi-Annual-2017-PHARMACARE-15082017.pdf
General-Assembly-Date-PHARMACARE-07082017.pdf
General-Assembly-Change-Date-PHARMACARE-27072017.pdf
General-Assembly-Date-PHARMACARE-10072017.pdf
FS-Quarter1-2017--PHARMACARE-02052017.pdf
FS-Quarter1-2017-PHARMACARE-02052017.pdf
Board-Meeting-Date-PHARMACARE-11042017-.pdf
Discl_Related Parties_PHARMACARE_03042017.pdf
Discl_Related Parties1_PHARMACARE_20022017.pdf
Discl_Related Parties_PHARMACARE_20022017.pdf
Board-Meeting-Decisions-PHARMACARE-16022017-.pdf
Board-Meeting-Decisions-PHARMACARE-16022017.pdf
Press-Rel-FS-Annual-Priliminary-PHARMACARE-16022017-.pdf
Press-Rel-FS-Annual-Priliminary-PHARMACARE-16022017.pdf
FS-Annual-Preliminary-2016-PHARMACARE-15022017.pdf
Discl_Related Parties_PHARMACARE_18012017.pdf
Discl_Related Parties_PHARMACARE_09012017.pdf
Discl_Related Parties1_PHARMACARE_09012017.pdf
Discl_Related Parties_PHARMACARE_27122016.pdf
Discl_Related Parties_PHARMACARE_21112016.pdf
Board-Meeting-Decisions-PHARMACARE-17112016.pdf
Discl_Related Parties_PHARMACARE_09112016.pdf
Discl_Related Parties1_PHARMACARE_09112016.pdf
Board-Meeting-Date-PHARMACARE-01112016.pdf
Discl_Related Parties_PHARMACARE_28092016.pdf
Discl_Related Parties_PHARMACARE_20102016.pdf
Discl_Related Parties_PHARMACARE_24102016.pdf
Discl_Related Parties_PHARMACARE_27102016.pdf
Press-FS-Quarter3-2016-PHARMACARE-31102016.pdf
FS-Quarter3-2016-PHARMACARE-31102016.pdf
Discl_Related Parties_PHARMACARE_14082016.pdf
Discl_Related Parties_PHARMACARE_05092016.pdf
Discl_Related Parties_PHARMACARE_07092016.pdf
Discl_Related Parties_PHARMACARE_26092016.pdf
Discl_Related Parties1_PHARMACARE_26092016.pdf
Press-FS-Semi-Annual-2014-PHARMACARE-17082014.pdf
Press-FS-Quarter3-2014-PHARMACARE-16112014.pdf
Press-Rel-FS-Annual-Priliminary-PHARMACARE-19022015.pdf
Press-FS-Semi-Annual-2016-PHARMACARE-23082016.pdf
Board-Member-Representative-Change-PHARMACARE-10082016.pdf
General-Assembly-Date-PHARMACARE-04062015.pdf
General-Assembly-Decisions-PHARMACARE-21062015.pdf
General-Assembly-Date-PHARMACARE-17042016.pdf
Board-Meeting-Decisions-PHARMACARE-11082016.pdf
FS-Quarter3-2014-PHARMACARE-16112014.pdf
FS-Quarter1-2015-PHARMACARE-12052015.pdf
FS-Quarter3-2015-PHARMACARE-29102015-.pdf
FS-Semi-Annual-2013-PHARMACARE-15082013.pdf
FS-Semi-Annual-2014-PHARMACARE-16082014.pdf
FS-Semi-Annual-2016-PHARMACARE-22082016.pdf
FS-Annual-Audited-2012-USD-PHARMACARE.pdf
FS-Audited-2013-PHARMACARE-29052014.pdf
Annual-Report-2013-PHARMACARE-09062014
FS-Annual-Preliminary-2013-PHARMACARE-13022014.pdf
FS-Annual-Preliminary-2014-PHARMACARE-19022015 .pdf
Board-Meetings-Decisions-PHARMACARE-24032016.pdf
Board-Meeting-Date-PHARMACARE-09052016.pdf
Board-Meeting-Decisions-PHARMACARE-16052016-.pdf
Board-Meeting-Decisions-PHARMACARE-13072016-.pdf
Close Price3.39Trades Count0
High Price3.39Low Price3.39
Trade Value ($)0Trade Volume0

Summary Period :         
Or : From :    To :

Trade Summary Chart

Basic Information
Establish Date
1986
Listing Date
23/04/2013
Symbol
PHARMACARE
MARKET CLASS
2
GM
Bassim Subhi Farah Khoury Nasr (Chief Executive Officer)
Termination Date of Board
21/08/2019
H.O. Location
Ramallah
No. of Branches
1
No. of Offices
0
Auditors
Saba & Co (Member of Deloitte Touche Tohmatsu)
Sector
Industry Sector
Currency
USD
Telephone
22900680
Fax
22900189
P.O. Box
677
Website
Last Update
5/2/2019
Chairman
Bassim Subhi Farah Khoury Nasr
Board Members
Bassam Yousef Ibrahim Yousef
PAUL MICHAEL AUGUST FRANZ WIRTZ
Sandra Issa Tawfiq Khoury Nasr
Tawfik Issa Tawfik Habesch
Azmi Rateb Fares Abu Hasan
R‘afat Ibrahim R‘afat Al Muthafar
Reach for invest. & Develop. - Holding/Hamza Azzam Mohamad Said Aloul
Ramzi Boulos Albert Boulos Noursi
Bank Of Palestine/Hashem Hani Hashem Shawa
Al-Watanieh securities Co- All Rights Reserved © 2019
Site Map    Contact Us